Table 3.
Outpatient quality metrics at index ambulatory visit
Total | 2019 | 2020 | p | |
---|---|---|---|---|
Appropriate anticoagulation decision | 1,804 (92.7) | 850 (93.8) | 954 (91.7) | 0.077 |
Inappropriate AAD and permanent AF | 1 (0.1) | 0 (0.0) | 1 (0.1) | 0.350 |
Inappropriate AAD and SHD | 2 (0.1) | 0 (0.0) | 2 (0.2) | 0.186 |
Inappropriate dofetilide or sotalol in ESRD | 0 (0.0) | 0 (0.0) | 0 (0.0) | NA |
Inappropriate non-dihydropyridine CCB in HFrEF | 6 (0.3) | 2 (0.2) | 4 (0.4) | 0.515 |
β-blocker prescribed when EF ≤40% | 206 | 80 (89.88) | 102 (87.17) | 0.548 |
Inappropriate DOAC and mechanical heart valve | 1 (0.1) | 1 (0.1) | 0 (0.0) | 0.283 |
Values are presented as n (%).
AAD = antiarrhythmic drug; AF = atrial fibrillation; CCB = calcium channel blocker; DOAC = direct oral anticoagulant; EF = ejection fraction; ESRD = end stage renal disease; HFrEF = heart failure with reduced ejection fraction; SHD = structural heart disease.